9
Participants
Start Date
February 1, 2022
Primary Completion Date
September 30, 2022
Study Completion Date
September 30, 2022
Pre-dilution online hemodiafiltration with citrate dialysate
After enrollment, all patients began a 2-week run-in period with conventional dialysis fluid containing acetate and the lowest dose of unfractionated heparin. The investigator titrated the heparin dose by reducing the dose step by step, 25% in each step, until the final minimal dose was achieved. The experimental study consisted of 3 phases, 4 weeks in each phase, and the phases were separated by 1-week washout periods. Phase 1 used CD with 50% of the heparin dose of the baseline. Phases 2 and 3 used 25% heparin and no heparin, respectively. New dialyzers were introduced at the beginning of each phase and the heparin dose was resumed during the washout phase. The calcium concentration in the dialysis fluid was kept constant (1.5 mmol/L) to allow evaluation of the effect of CD on calcium balance
Post-dilution hemodiafiltration with citrate dialysate
same protocol with post-dilution Ol-HDF in these same patients for the later 12 weeks.
Faculty of Medicine ,Vajira hospital,Navamindradhiraj University, Bangkok
Faculty of Medicine ,Vajira Hospital, Bangkok
Bangkok Metropolitan Administration Medical College and Vajira Hospital
OTHER_GOV